Wellcome Trust Sanger Institute

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novartis And Ionis Build On Earlier Akc

Morningside Ventures launched Adiso Therapeutics on 10 March with more than $60m invested to date in the Concord, MA-based start-up focusing on the underlying biology of inflammatory diseases without

"COVID-19 is a great reminder and a testament that biopharma's core mission is to meet patient and society's needs." These words of Lihua Yu , president and chief data science officer of Eisai Co.,

AnaBios Brings In $10m Series B Round, Including $4.2m From Principia AnaBios Corp. (focused on pain and cardiovascular and neurodegenerative diseases) closed a $10m Series B round, which included